Extra-domain B fibronectin - quantitative analysis in different carcinoma types as a precondition for targeted therapy

被引：0
|
作者：
Wagner, C.
Berndorff, D.
Berndt, A.
Zardi, L.
Dinkelborg, L. M.
Kosmehl, H.
机构：
[1] HELIOS Klinikum, Inst Pathol, Erfurt, Germany
[2] Univ Klinikum Jena, Inst Pathol, Jena, Germany
[3] Inst Giannina Gaslini, Genoa, Italy
来源：
PATHOLOGY RESEARCH AND PRACTICE | 2007年 / 203卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
404
引用
收藏
页码：403 / 403
页数：1
相关论文
共 25 条
  • [1] The Extra-Domain B of Fibronectin is Mechanically Labile
    He, Chengzhi
    Xie, Yayan
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 619A - 619A
  • [2] Incorporation of Extra-domain B into Fibronectin mediates local dimerization.
    Schiefner, Andre
    Gebauer, Michaela
    Skerra, Arne
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2010, 66 : S120 - S120
  • [3] ROLE OF EXTRA-DOMAIN B FIBRONECTIN IN MODULATING GLIOBLASTOMA CELL INVASIVE PROPERTIES
    Kang, Bo Ram
    Yun, Minji
    Bae, Eunkyung
    Chong, Kyuha
    NEURO-ONCOLOGY, 2024, 26
  • [4] Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
    Lieverse, Relinde I. Y.
    Marcus, Damienne
    van der Wiel, Alexander M. A.
    Van Limbergen, Evert J.
    Theys, Jan
    Yaromina, Ala
    Lambin, Philippe
    Dubois, Ludwig J.
    MOLECULAR ONCOLOGY, 2020, 14 (07) : 1555 - 1568
  • [5] Extra-domain B fibronectin matrix in atherosclerotic lesions indicating vulnerable plaques
    Thomas, M.
    Berndt, A.
    Dahse, R.
    Neri, D.
    Kosmehl, H.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 327 - 327
  • [6] Discovery and investigation of lead compounds as binders to the extra-domain B of the angiogenesis marker, fibronectin
    Scheuermann, J
    Volonterio, A
    Zerbe, O
    Zanda, M
    Neri, D
    DRUG DEVELOPMENT RESEARCH, 2003, 58 (03) : 268 - 282
  • [7] Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin
    Matter, CM
    Schuler, PK
    Alessi, P
    Meier, P
    Ricci, R
    Zhang, DM
    Halin, C
    Castellani, P
    Zardi, L
    Hofer, CK
    Montani, M
    Neri, D
    Lüscher, TF
    CIRCULATION RESEARCH, 2004, 95 (12) : 1225 - 1233
  • [8] Combinatorial Design of an Anticalin Directed against the Extra-Domain B for the Specific Targeting of Oncofetal Fibronectin
    Gebauer, Michaela
    Schiefner, Andre
    Matschiner, Gabriele
    Skerra, Arne
    JOURNAL OF MOLECULAR BIOLOGY, 2013, 425 (04) : 780 - 802
  • [9] Diagnostic and therapeutic applications of recombinant antibodies: Targeting the extra-domain B of fibronectin, A marker of tumor angiogenesis
    Ebbinghaus, C
    Scheuermann, J
    Neri, D
    Elia, G
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (13) : 1537 - 1549
  • [10] Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma
    Saw, Phei Er
    Xu, Xiaoding
    Kang, Bo Ram
    Lee, Jungsul
    Lee, Yeo Song
    Kim, Chungyeul
    Kim, Hyungsin
    Kang, Shin-Hyuk
    Na, Yoo Jin
    Moon, Hong Joo
    Kim, Joo Han
    Park, Youn-Kwan
    Yoon, Wonki
    Kim, Jong Hyun
    Kwon, Taek-Hyun
    Choi, Chulhee
    Jon, Sangyong
    Chong, Kyuha
    THERANOSTICS, 2021, 11 (02): : 941 - 957
123